The Scientist

» data sharing and immunology

Most Recent

image: WHO: Share Trial Data

WHO: Share Trial Data

By | April 15, 2015

The World Health Organization again calls upon researchers to register clinical trial details in freely accessible databases before initiation of the study.

0 Comments

image: Studying Ebola Survivors

Studying Ebola Survivors

By | April 6, 2015

A scientist jumps at the chance to study the blood of four Ebola survivors to better understand how the immune system responds to the deadly virus. 

1 Comment

image: Cancer Immunotherapist

Cancer Immunotherapist

By | April 1, 2015

Scientist to Watch Yvonne Saenger explains recent advances in using biomarkers to identify cancer patients who might benefit most from immunotherapy.

1 Comment

image: Manipulative Microbiomes

Manipulative Microbiomes

By | April 1, 2015

Gut bacteria control tumor growth via the mammalian immune system.

3 Comments

image: Yvonne Saenger: Immunotherapy Pioneer

Yvonne Saenger: Immunotherapy Pioneer

By | April 1, 2015

Assistant Professor, Department of Medicine, Columbia University. Age: 41

5 Comments

image: T Cells of the Skin

T Cells of the Skin

By | March 18, 2015

A census of adaptive immune system components in human skin reveals a variety of resident and traveling memory T cells.

2 Comments

image: Sharing Longevity Data

Sharing Longevity Data

By | March 1, 2015

Aging research would greatly benefit from consistently making annotated life span data available.

0 Comments

image: Fighting Allergy with Allergen

Fighting Allergy with Allergen

By | February 25, 2015

Babies who ate peanuts were less likely to develop an allergy to the food by the time they hit kindergarten, according to a new study.

4 Comments

image: Long-Lived Immunotherapy Stem Cells

Long-Lived Immunotherapy Stem Cells

By | February 4, 2015

Genetically modified T memory stem cells persist in patients for more than 10 years, and can differentiate into a variety of T cell types.

1 Comment

image: Ebola Drug Trial Canceled

Ebola Drug Trial Canceled

By | February 2, 2015

As the number of Ebola cases declines, Chimerix is unable to recruit enough patients for its trial in Liberia testing the antiviral drug brincidofovir.

0 Comments

Popular Now

  1. Scientists Continue to Use Outdated Methods
  2. Secret Eugenics Conference Uncovered at University College London
  3. Like Humans, Walruses and Bats Cuddle Infants on Their Left Sides
  4. How Do Infant Immune Systems Learn to Tolerate Gut Bacteria?
AAAS